Rothschild Investment LLC’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Buy
248
+61
+33% +$34.2K ﹤0.01% 977
2026
Q1
$105K Sell
187
-3
-2% -$1.92K 0.01% 863
2025
Q4
$129K Buy
190
+8
+4% +$5.45K 0.01% 745
2025
Q3
$116K Hold
182
0.01% 763
2025
Q2
$97.6K Sell
182
-65
-26% -$31.1K 0.01% 650
2025
Q1
$104K Sell
247
-27
-10% -$11.7K 0.01% 624
2024
Q4
$113K Sell
274
-17
-6% -$7.46K 0.01% 608
2024
Q3
$147K Buy
291
+9
+3% +$4.37K 0.01% 576
2024
Q2
$137K Sell
282
-49
-15% -$24.6K 0.01% 565
2024
Q1
$179K Buy
331
+10
+3% +$5.46K 0.01% 487
2023
Q4
$178K Buy
+321
New +$151K 0.01% 431

Other funds holding IDXX

Rothschild Investment LLC's IDXX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Idexx Laboratories (IDXX) stake by 33% in Q2 2026, buying an estimated $34.2K and bringing the position to 248 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

Rothschild Investment LLC first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $179K in Q1 2024. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Rothschild Investment LLC held 248 shares of Idexx Laboratories worth $131K as of Q2 2026.
  • Rothschild Investment LLC bought 61 Idexx Laboratories shares in Q2 2026, an estimated $34.2K.
  • Idexx Laboratories made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #977 holding.
  • Rothschild Investment LLC first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Rothschild Investment LLC's Idexx Laboratories position peaked at $179K in Q1 2024.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.